Beta Bionics Stock
Beta Bionics, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Sean T. Saint
- Employees
- 422
- Market cap
- $736 M
- IPO
- 30/01/2025
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin…
Beta Bionics stock: price history
1D
-5.5%
1W
-7.3%
1M
-26.3%
6M
+26.0%
YTD
-46.3%
1Y
-20.7%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
27/10/2026 (in 10 days)
Volatility around earnings
~11% stronger price swings than usual
Ask the agents about Beta Bionics
Analyst assessment of Beta Bionics
PRICE TARGET LOW
US$16.00
CONSENSUS
US$24.75
MEDIAN
US$26.00
PRICE TARGET HIGH
US$30.00
0
STRONG BUY
6
BUY
2
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 24/09/2026
Beta Bionics stock metrics
P/E
-9.73
P/B
2.84
EV/EBITDA
-9.77
RETURN ON EQUITY
-9.1%
NET MARGIN
-73.1%
DEBT/EQUITY
0.03
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
44.5%
FLOAT SHARES
20,036,158
AVG. DAILY VOLUME (30D)
1,344,402
Insider transactions (SEC)
Hopman Mark
Hopman Mark
Jones Christy
Mensinger Mike
Hopman Mark
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -5.5%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Beta Bionics stock
What does Beta Bionics do?
Beta Bionics, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Sean T. Saint, the company employs around 422 people.
The IPO was on 30/01/2025; the stock trades on NASDAQ under the ticker BBNX.
What do analysts say about Beta Bionics stock?
8 analysts rate the stock, the consensus is Buy (as of 24/09/2026).
The average price target is US$24.75, ranging from US$16.00 to US$30.00, with a median of US$26.00.
This is an external assessment, not a statement by Market Jury.
When does Beta Bionics report next?
The next earnings date is 27/10/2026.
Around past earnings, price swings were roughly 11% stronger than usual.
Does Beta Bionics pay a dividend?
No, Beta Bionics currently does not pay a dividend.
Which stocks are comparable to Beta Bionics?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Beta Bionics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Beta Bionics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.